Suppr超能文献

大鼠肝内皮细胞对乙酰化低密度脂蛋白、内皮细胞修饰的低密度脂蛋白及甲醛处理的血清白蛋白的内吞作用。通过共同受体摄取的证据。

Endocytosis of acetylated low-density lipoprotein, endothelial cell-modified low-density lipoprotein, and formaldehyde-treated serum albumin by rat liver endothelial cells. Evidence of uptake via a common receptor.

作者信息

Eskild W, Henriksen T, Skretting G, Blomhoff R, Berg T

机构信息

Institute for Nutrition Research, School of Medicine, University of Oslo, Blindern, Norway.

出版信息

Scand J Gastroenterol. 1987 Dec;22(10):1263-9. doi: 10.3109/00365528708996474.

Abstract

Formaldehyde-treated serum albumin (FSA) and acetylated low-density lipoprotein (Ac-LDL) are taken up in vivo and in vitro by the sinusoidal endothelial cells of the liver. It is not known whether both these ligands are removed by the scavenger receptor. We have studied the effect of increasing concentrations of unlabeled FSA, Ac-LDL, and endothelial cell-modified LDL (Ec-LDL) on the endocytosis of trace amounts of these ligands labeled with 125I. Uptake of 125I-Ac-LDL and 125I-Ec-LDL was strongly inhibited by FSA. Likewise, Ac-LDL and Ec-LDL reduced the uptake of 125I-FSA effectively. Our data indicate that these modified LDLs and FSA are bound to and internalized via the same receptor on liver endothelial cells.

摘要

甲醛处理的血清白蛋白(FSA)和乙酰化低密度脂蛋白(Ac-LDL)在体内和体外均可被肝脏的窦状内皮细胞摄取。目前尚不清楚这两种配体是否都通过清道夫受体被清除。我们研究了未标记的FSA、Ac-LDL和内皮细胞修饰的低密度脂蛋白(Ec-LDL)浓度增加对微量用125I标记的这些配体的内吞作用的影响。FSA强烈抑制125I-Ac-LDL和125I-Ec-LDL的摄取。同样,Ac-LDL和Ec-LDL也有效降低了125I-FSA的摄取。我们的数据表明,这些修饰的低密度脂蛋白和FSA通过肝脏内皮细胞上的同一受体结合并内化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验